SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Minerva Neurosciences, Inc.
Date: March 16, 2026 · CIK: 0001598646 · Accession: 0000000000-26-002667

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-294203

Date
March 16, 2026
Author
Remy Luthringer
Form
UPLOAD
Company
Minerva Neurosciences, Inc.

Letter

March 16, 2026 Remy Luthringer Chief Executive Officer Minerva Neurosciences, Inc. 1500 District Avenue Burlington, MA 01803 Re:Minerva Neurosciences, Inc. Registration Statement on Form S-3 Filed March 11, 2026 File No. 333-294203 Dear Remy Luthringer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Pengli Li

Show Raw Text
March 16, 2026
Remy Luthringer
Chief Executive Officer
Minerva Neurosciences, Inc.
1500 District Avenue
Burlington, MA 01803
Re:Minerva Neurosciences, Inc.
Registration Statement on Form S-3
Filed March 11, 2026
File No. 333-294203
Dear Remy Luthringer:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Pengli Li